Three structurally related non-xanthine compounds, CGS 15943, ZM 241385 and
SCH 58261, are potent A(2A) adenosine receptor antagonists and have been u
sed as tools in many pharmacological studies. We have now characterized the
ir affinity and selectivity profile on human adenosine receptors stably tra
nsfected into either CHO cells (A(1) and A(2B) receptors) or HEK-293 cells
(A(2A) and A(3) receptors). In binding studies using [H-3]SCH 58261 as a ra
dioligand, the three compounds were equally potent at A(2A) receptors, thei
r K-i value being less than 1 nM. Affinity for A(1) and A(3) receptors was
measured using [H-3]DPCPX and [I-125]AB-MECA as radioligands. Given the lac
k of selective ligands, interaction with A(2B) receptors was assessed using
the cAMP accumulation assay following stimulation by the adenosine recepto
r agonist N-ethylcarboxamidoadenosine (NECA). CGS 15943 was almost as poten
t at A(1) receptors (K-i 3.5 nM) as at A(2A) receptors, showed moderate aff
inity for A(3) receptors (K-i 95 nM) and also interacted with A(2B) Pecepto
rs (K-i 44 nM; pA(2) 7.5). ZM 241385 showed little affinity for A(1) recept
ors (K-i 255 nM), and did not interact with A(3) receptors (K-i >10 mu M);
however, it displayed moderate affinity for A(2B) receptors (K-i 50 nM; pA(
2) 7.3). SCH 58261 had weak affinity for A(1) receptors (K-i 287 nM), no in
teraction with A(3) receptors (K-i > 10 mu M), and showed negligible intera
ction with A(2B) receptors (K-i 5 mu M; pA(2) 6.0). These data indicate tha
t SCH 58261 is the most selective A2A antagonist currently available. Moreo
ver, the different receptor selectivity of these three chemically related c
ompounds provides useful information to progress with structure-activity re
lationship studies.